Skip to main content

Advertisement

Table 4 Reimbursement adequacy index and social health insurance system

From: International comparison of the factors influencing reimbursement of targeted anti-cancer drugs

  UK Canada Australia Sweden France * Japan Korea Taiwan Germany *
Reimbursement adequacy index 0.79 0.68 0.63 0.58 0.58 0.58 0.53 0.53 0.47
Financing system 76% General tax +18% National insurance +3% user charge 100% General tax 98.5% General tax +1.5% Levy 100% General tax 33% General tax +43% National insurance + Levies + other social security Premium Premium Premium Premium
Health technology assessment (HTA) Government independent Government independent Government agency Government agency Government agency N/A Government agency Government agency Government independent
Date of HTA foundation 1999 1990 1993 1987 2004 N/A 2009 2007 2004
Form of Health Security National Healthcare Service Social Health Insurance Social Health Insurance National Healthcare Service Social Health Insurance Social Health Insurance Social Health Insurance Social Health Insurance Social Health Insurance
  1. N/A, not available.
  2. *Germany and France have the HTA agencies that apply an evaluation process based on evidence but not based on comparative cost effectiveness.